Skip to main content
SpringerLink
Log in

Assessment of Pulmonary Vascular Disease

  • Chapter
  • First Online:
Cardiac CT Imaging

  • 1843 Accesses

Abstract

Pulmonary vascular diseases span a variety of disease entities including pulmonary arterial hypertension (PAH), pulmonary venous hypertension, pulmonary embolism, pulmonary arteriovenous malformation, pulmonary arterial stenosis, pulmonary arterial aneurysm, pulmonary veno-occlusive disease (PVOD), and pulmonary capillary hemangiomatosis (see Sect. 18.1.2). In this chapter, we briefly review pulmonary hypertension (PH) and pulmonary embolism (PE), including their cardiac computed tomography (CT) findings.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol. 2009;53:1573–1619.

    Article  PubMed  Google Scholar 

  2. Fleischner FG. Pulmonary embolism. Clin Radiol. 1962;13:169–182.

    Article  PubMed  CAS  Google Scholar 

  3. Simon M, Sasahara AA, Cannilla JE. The radiology of pulmonary hypertension. Semin Roentgenol. 1967;2:368–388.

    Article  Google Scholar 

  4. Kuriyama K, Gamsu G, Stern RG, Cann CE, Herfkens RJ, Brundage BH. CT-determined pulmonary artery diameters in predicting pulmonary hypertension. Invest Radiol. 1984;19:16–22.

    Article  PubMed  CAS  Google Scholar 

  5. Kuo PC, Plotkin JS, Johnson LB, et al. Distinctive clinical features of portopulmonary hypertension. Chest. 1997;112:980–986.

    Article  PubMed  CAS  Google Scholar 

  6. Ng CS, Wells AU, Padley SP. A CT sign of chronic pulmonary arterial hypertension: the ratio of main pulmonary artery to aortic diameter. J Thorac Imaging. 1999;14:270–278.

    Article  PubMed  CAS  Google Scholar 

  7. Tan RT, Kuzo R, Goodman LR, et al. Utility of CT scan evaluation for predicting pulmonary hypertension in patients with parenchymal lung disease. Chest. 1998;113:1250–1256.

    Article  PubMed  CAS  Google Scholar 

  8. Edwards PD, Bull RK, Coulden R. CT measurement of main pulmonary artery diameter. Br J Radiol. 1998;71:1018–1020.

    PubMed  CAS  Google Scholar 

  9. Chatterjee K, De Marco T, Alpert JS. Pulmonary hypertension: hemodynamic diagnosis and management. Arch Int Med. 2002;162:1925–1933.

    Article  Google Scholar 

  10. Baque-Juston MC, Wells AU, Hansell DM. Pericardial thickening or effusion in patients with pulmonary artery hypertension: a CT study. AJR Am J Roentgenol. 1999;172:361–364.

    PubMed  CAS  Google Scholar 

  11. Perloff JK, Hart EM, Greaves SM, Miner PD, Child JS. Proximal pulmonary arterial and intrapulmonary radiologic features of Eisenmenger syndrome and primary pulmonary hypertension. Am J Cardiol. 2003;92:182–187.

    Article  PubMed  Google Scholar 

  12. Griffin N, Allen D, Wort J, et al. Eisenmenger syndrome and idiopathic pulmonary arterial hypertension: do parenchymal lung changes reflect aetiology? Clin Radiol. 2007;62:587–595.

    Article  PubMed  CAS  Google Scholar 

  13. Van Der Meer RW, Pattynama PM, Van Strijen MJ, et al. Right ventricular dysfunction and pulmonary obstruction index at helical CT: prediction of clinical outcome during 3-month follow-up in patients with acute pulmonary embolism. Radiology. 2005;235:798–803.

    Article  PubMed  Google Scholar 

  14. Reid JH, Murchison JT. Acute right ventricular dilatation: a new helical CT sign of massive pulmonary embolism. Clin Radiol. 1998;53:694–698.

    Article  PubMed  CAS  Google Scholar 

  15. Bossone E, Duong-Wagner TH, Paciocco G, et al. Echocardiographic features of primary pulmonary hypertension. J Am Soc Echocardiogr. 1999;12:655–662.

    Article  PubMed  CAS  Google Scholar 

  16. Ryan T, Petrovic O, Dillon JC, Feigenbaum HF, Conley HJ, Armstrong W. An echocardiographic index for separation of right ventricular volume and pressure overload. J Am Coll Cardiol. 1985;5:918–924.

    Article  PubMed  CAS  Google Scholar 

  17. Yeh BM, Kurzman P, Foster E, Qayyum A, Joe B, Coakley F. Clinical relevance of retrograde inferior vena cava or hepatic vein opacification during contrast-enhanced CT. Am J Roentgenol. 2004;183:1227–1232.

    Google Scholar 

  18. Simonneau G, Robbins IM, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2009;54:S43–S54.

    Article  PubMed  Google Scholar 

  19. Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension: a national prospective study. Ann Intern Med. 1987;107:216–223.

    PubMed  CAS  Google Scholar 

  20. Loyd JE, Butler MG, Foroud TM, Conneally PM, Phillips JA, Newman JH. Genetic anticipation and abnormal gender ratio at birth in familial primary pulmonary hypertension. Am J Respir Crit Care Med. 1995;152:93–97.

    PubMed  CAS  Google Scholar 

  21. Loyd JE, Primm RK, Newman JH. Familial primary pulmonary hypertension: clinical patterns. Am Rev Respir Dis. 1984;129:194–197.

    PubMed  CAS  Google Scholar 

  22. Cogan JD, Pauciulo MW, Batchman AP, et al. High frequency of BMPR2 exonic deletions/ duplications in familial pulmonary arterial hypertension. Am J Respir Crit Care Med. 2006;174:590–598.

    Article  PubMed  CAS  Google Scholar 

  23. Aldred MA, Vijayakrishnan J, James V, et al. BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertension. Hum Mutat. 2006; 27:212–213.

    Article  PubMed  Google Scholar 

  24. Machado RD, Aldred MA, James V, et al. Mutations of the TGF- β type II receptor BMPR2 in pulmonary arterial hypertension. Hum Mutat. 2006;27:121–132.

    Article  PubMed  CAS  Google Scholar 

  25. Thomson JR, Machado RD, Pauciulo MW, et al. Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-β family. J Med Genet. 2000;37:741–745.

    Article  PubMed  CAS  Google Scholar 

  26. Chaouat A, Coulet F, Favre C, et al. Endoglin germline mutation in a patient with hereditary haemorrhagic telangiectasia and dexfenfluramine associated pulmonary arterial hypertension. Thorax. 2004;59: 446–448.

    Article  PubMed  CAS  Google Scholar 

  27. Trembath RC, Thomson JR, Machado RD, et al. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. N Engl J Med. 2001;345:325–334.

    Article  PubMed  CAS  Google Scholar 

  28. McGoon M, Gutterman D, Steen V, et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence based clinical practice guidelines. Chest. 2004;126:14S–34S.

    Article  PubMed  Google Scholar 

  29. Hachulla E, Gressin V, Guillevin L, et al. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum. 2005;52:3792–3800.

    Article  PubMed  Google Scholar 

  30. Mukerjee D, St George D, Coleiro B, et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis. 2003;62:1088–1093.

    Article  PubMed  CAS  Google Scholar 

  31. Tanaka E, Harigai M, Tanaka M, Kawaguchi Y, Hara M, Kamatani N. Pulmonary hypertension in systemic lupus erythematosus: evaluation of clinical characteristics and response to immunosuppressive treatment. J Rheumatol. 2002;29:282–287.

    PubMed  Google Scholar 

  32. Asherson RA, Higenbottam TW, Dinh Xuan AT, Khamashta MA, Hughes GR. Pulmonary hypertension in a lupus clinic: experience with twenty-four patients. J Rheumatol. 1990;17:1292–1298.

    PubMed  CAS  Google Scholar 

  33. Burdt MA, Hoffman RW, Deutscher SL, Wang GS, Johnson JC, Sharp GC. Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. Arthritis Rheum. 1999;42:899–909.

    Article  PubMed  CAS  Google Scholar 

  34. Jaïs X, Launay D, Yaici A, et al. Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases. Arthritis Rheum. 2008;58:521–531.

    Article  PubMed  Google Scholar 

  35. Launay D, Hachulla E, Hatron PY, Jaïs X, Simonneau G, Humbert M. Pulmonary arterial hypertension: a rare complication of primary Sjögren syndrome: report of 9 new cases and review of the literature. Medicine (Baltimore). 2007;86:299–315.

    Article  Google Scholar 

  36. Bunch TW, Tancredi RG, Lie JT. Pulmonary hypertension in polymyositis. Chest. 1981;79:105–107.

    Article  PubMed  CAS  Google Scholar 

  37. Dawson JK, Goodson NG, Graham DR, Lynch MP. Raised pulmonary artery pressures measured with Doppler echocardiography in rheumatoid arthritis patients. Rheumatology (Oxford). 2000;39:1320–1325.

    Article  CAS  Google Scholar 

  38. Coghlan JG, Handler C. Connective tissue associated pulmonary arterial hypertension. Lupus. 2006;15:138–142.

    Article  PubMed  CAS  Google Scholar 

  39. Lettieri CJ, Nathan SD, Barnett SD, et al. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest. 2006;129:746–752.

    Article  PubMed  Google Scholar 

  40. Nunes H, Humbert M, Capron F, et al. Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis. Thorax. 2006;61:68–74.

    Article  PubMed  CAS  Google Scholar 

  41. Zisman DA, Karlamangla AS, Ross DJ, et al. High-resolution chest CT findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis. Chest. 2007;132:773–779.

    Article  PubMed  Google Scholar 

  42. Eisenmenger V. Die angeborene defecte der kammersheidewand das herzen. Z Klin Med. 1897;132:131.

    Google Scholar 

  43. Wood P. The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt. Br Med J. 1958;2:701–709.

    Article  PubMed  CAS  Google Scholar 

  44. Daliento L, Somerville J, Presbitero P, et al. Eisenmenger syndrome: factors relating to deterioration and death. Eur Heart J. 1998;19:1845–1855.

    Article  PubMed  CAS  Google Scholar 

  45. Besterman E. Atrial septal defect with pulmonary hypertension. Br Heart J. 1961;23:587–598.

    Article  PubMed  CAS  Google Scholar 

  46. Hoffman JI, Rudolph AM. The natural history of ventricular septal defects in infancy. Am J Cardiol. 1965;16:634–653.

    Article  PubMed  CAS  Google Scholar 

  47. Galiè N, Manes A, Palazzini M, et al. Management of pulmonary arterial hypertension associated with congenital systemic-to pulmonary shunts and Eisenmenger’s syndrome. Drugs. 2008;68:1049–1066.

    Article  PubMed  Google Scholar 

  48. Shaw AP, Ghareed A. The pathogenesis of pulmonary schistosomiasis in Egypt with special reference to Ayerza’s disease. J Pathol Bacteriol. 1938;46:401–424.

    Article  Google Scholar 

  49. de Cleva R, Herman P, Pugliese V, et al. Prevalence of pulmonary hypertension in patients with hepatosplenic Mansonic schistosomiasis – prospective study. Hepatogastroenterology. 2003;50:2028–2030.

    PubMed  Google Scholar 

  50. Lapa MS, Ferreira EV, Jardim C, Martins Bdo C, Arakaki JS, Souza R. Clinical characteristics of pulmonary hypertension patients in two reference centers in the city of Sao Paulo]. Rev Assoc Med Bras. 2006;52:139–143.

    Article  PubMed  Google Scholar 

  51. Chaves E. The pathology of the arterial pulmonary vasculature in Manson’s schistosomiasis. Chest. 1966;50:72–77.

    Article  CAS  Google Scholar 

  52. Gladwin MT, Sachdev V, Jison ML, et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med. 2004;350:886–895.

    Article  PubMed  CAS  Google Scholar 

  53. Reiter CD, Wang X, Tanus-Santos JE, et al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med. 2002;8:1383–1389.

    Article  PubMed  CAS  Google Scholar 

  54. Gladwin MT, Lancaster JR Jr, Freeman BA, Schechter AN. Nitric oxide’s reactions with hemoglobin: a view through the SNO-storm. Nat Med. 2003;9:496–500.

    Article  PubMed  CAS  Google Scholar 

  55. Mandel J, Mark EJ, Hales CA. Pulmonary veno-occlusive disease. Am J Respir Crit Care Med. 2000;162:1964–1973.

    PubMed  CAS  Google Scholar 

  56. Frazier AA, Franks TJ, Mohammed TL, Ozbudak IH, Galvin JR. From the Archives of the AFIP: pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis. Radiographics. 2007;27:867–882.

    Article  PubMed  Google Scholar 

  57. Holcomb BW Jr, Loyd JE, Ely EW, Johnson J, Robbins IM. Pulmonary veno-occlusive disease: a case series and new observations. Chest. 2000;118:1671–1679.

    Article  PubMed  Google Scholar 

  58. Resten A, Maitre S, Humbert M, et al. Pulmonary hypertension: CT of the chest in pulmonary veno-occlusive disease. Am J Roentgenol. 2004;183:65–70.

    Google Scholar 

  59. Lantuéjoul S, Sheppard MN, Corrin B, Burke MM, Nicholson AG. Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis: a clinicopathologic study of 35 cases. Am J Surg Pathol. 2006;30:850–857.

    Article  PubMed  Google Scholar 

  60. Ozsoyoglu AA, Swartz J, Farver CF, Mohammed TL. High resolution computed tomographic imaging and pathologic features of pulmonary veno-occlusive disease: a review of three patients. Curr Probl Diagn Radiol. 2006;35:219–223.

    Article  PubMed  Google Scholar 

  61. Montani D, Achouh L, Dorfmuller P, et al. Pulmonary venoocclusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology. Medicine(Baltimore). 2008;87:220–233.

    Google Scholar 

  62. Rabiller A, Jaïs X, Hamid A, et al. Occult alveolar haemorrhage in pulmonary veno-occlusive disease. Eur Respir J. 2006;27:108–113.

    Article  PubMed  CAS  Google Scholar 

  63. Fraser KL, Tullis DE, Sasson Z, Hyland RH, Thornley KS, Hanly PJ. Pulmonary hypertension and cardiac function in adult cystic fibrosis: role of hypoxemia. Chest. 1999;115:1321–1328.

    Article  PubMed  CAS  Google Scholar 

  64. Cottin V, Nunes H, Brillet PY, et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J. 2005;26: 586–593.

    Article  PubMed  CAS  Google Scholar 

  65. Chaouat A, Bugnet AS, Kadaoui N, et al. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;172:189–194.

    Article  PubMed  Google Scholar 

  66. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ III. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998;158:585–593.

    Article  PubMed  CAS  Google Scholar 

  67. Tapson VF. Acute pulmonary embolism. N Engl J Med. 2008;358:1037–1052.

    Article  PubMed  CAS  Google Scholar 

  68. Heit JA. The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol. 2008;28:370–372.

    Article  PubMed  CAS  Google Scholar 

  69. Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J R Soc Med. 1989;82:203–205.

    PubMed  CAS  Google Scholar 

  70. Stein PD, Terrin ML, Hales CA, et al. Clinical, laboratory, roentgenographic and electrocardiographic findings in patients with acute pulmonary embolism and no pre-existing cardiac or pulmonary disease. Chest. 1991;100:598–603.

    Article  PubMed  CAS  Google Scholar 

  71. Stein PD, Willis PW III, DeMets DL, Greenspan RH. Plain chest roentgenogram in patients with acute pulmonary embolism and no pre-existing cardiac or pulmonary disease. Am J Noninvas Cardiol. 1987; 1:171–176.

    Google Scholar 

  72. Stein PD, Fowler SE, Goodman LR, et al. Multidetector computed tomography for acute pulmonary embolism. N Engl J Med. 2006;354: 2317–2327.

    Article  PubMed  CAS  Google Scholar 

  73. Qanadli SD, Hajjam ME, Mesurolle B, et al: Pulmonary embolism detection. Prospective evaluation of dual-section helical CT versus selective pulmonary arteriography in 157 patients. Radiology. 2000; 217:447–455.

    PubMed  CAS  Google Scholar 

  74. Winer-Muram HT, Rydberg J, Johnson MS, et al. Suspected acute pulmonary embolism: Evaluation with multi-detector row CT versus digital subtraction pulmonary arteriography. Radiology. 2004;233: 806–815.

    Article  PubMed  Google Scholar 

  75. Tapson VF, Humbert M. Incidence and prevalence of chronic thromboembolic pulmonary hypertension: from acute to chronic pulmonary embolism. Proc Am Thorac Soc. 2006;3:564–567.

    Article  PubMed  Google Scholar 

  76. Pengo V, Lensing AW, Prins MH, et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med. 2004;350:2257–2264.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Los Angeles, CA, USA

    Tae Young Choi MD

  2. Department of Medicine, Division of Cardiology, Harbor-UCLA Medical Center, Torrance, CA, USA

    Ronald J. Oudiz MD

Authors
  1. Tae Young Choi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ronald J. Oudiz MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tae Young Choi MD .

Editor information

Editors and Affiliations

  1. Los Angeles Biomedical Res. Institute, Dept. Cardiology, Harbor-UCLA Medical Center, W. Carson St. 1124, Torrance, 90502, USA

    Matthew J. Budoff

  2. Keck School of Medicine, University of Southern California, San Pablo St. 1510, Los Angeles, 90033, USA

    Jerold S. Shinbane

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag London Limited

About this chapter

Cite this chapter

Choi, T.Y., Oudiz, R.J. (2010). Assessment of Pulmonary Vascular Disease. In: Budoff, M., Shinbane, J. (eds) Cardiac CT Imaging. Springer, London. https://doi.org/10.1007/978-1-84882-650-2_18

Download citation

  • DOI: https://doi.org/10.1007/978-1-84882-650-2_18

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84882-649-6

  • Online ISBN: 978-1-84882-650-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation